RE:Q3 Given that they're nascent verticals, we can't expect meaningful income (other than marginal) from Medicall/EV until H1 2023. Otherwise, on the AI (Nexalogy) front, other than the private sector contracts announced, we could be surprised by an IDEAS-generated income...As such, we should disregard AI contract income as already known.
COVID testing income we should start disregarding and simply hope for pleasant surprises, as we know margins are progressively reducing, as a breadth of cheap tests have come on the market.
Bottom line, I think we could see interesting results during Q3.
cordillon wrote: I may be wrong but I doubt there will be much revenue if any from EV charging and Medi-Call. We already know what AI contracts we have. The only question is how much Covid testing income.